HQL
$14.10
abrdn Life Sciences Investors
Fund Family: abrdn Life Sciences Investors
Explore sections
1 Month
+3.60%
YTD
-2.77%
1 Year
-2.77%
3 Year
+39.46%
Top 10 Holdings (42.7% of portfolio)
- Regeneron Pharmaceuticals In…Manufacturing7.35%
- Amgen IncManufacturing7.28%
- Gilead Sciences IncManufacturing6.61%
- Vertex Pharmaceuticals IncManufacturing4.53%
- Alnylam Pharmaceuticals IncManufacturing3.45%
- BioMarin Pharmaceutical IncManufacturing3.44%
- State Street Institutional U…Unknown2.92%
- Insmed IncUnknown2.42%
- ARGENX SEManufacturing2.41%
- BioNTech SEManufacturing2.34%
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | Regeneron Pharmaceuticals Inc | REGN | Manufacturing | 7.35% |
| 2 | Amgen Inc | AMGN | Manufacturing | 7.28% |
| 3 | Gilead Sciences Inc | GILD | Manufacturing | 6.61% |
| 4 | Vertex Pharmaceuticals Inc | VRTX | Manufacturing | 4.53% |
| 5 | Alnylam Pharmaceuticals Inc | ALNY | Manufacturing | 3.45% |
| 6 | BioMarin Pharmaceutical Inc | BMRN | Manufacturing | 3.44% |
| 7 | State Street Institutional US Government Money Market Fund | GVMXX | Unknown | 2.92% |
| 8 | Insmed Inc | IM8N | Unknown | 2.42% |
| 9 | ARGENX SE | ARGX | Manufacturing | 2.41% |
| 10 | BioNTech SE | BNTX | Manufacturing | 2.34% |
Fund Information
Net Assets$395.93M
Total Holdings96
Fund Familyabrdn Life Sciences Investors